MY161415A - A homeopathic formulation - Google Patents

A homeopathic formulation

Info

Publication number
MY161415A
MY161415A MYPI2010005054A MYPI2010005054A MY161415A MY 161415 A MY161415 A MY 161415A MY PI2010005054 A MYPI2010005054 A MY PI2010005054A MY PI2010005054 A MYPI2010005054 A MY PI2010005054A MY 161415 A MY161415 A MY 161415A
Authority
MY
Malaysia
Prior art keywords
homeopathic formulation
homeopathic
formulations
formulation
causticum
Prior art date
Application number
MYPI2010005054A
Other languages
English (en)
Inventor
Gunvant Devichand Oswal
Pooja Gunvant Oswal
Original Assignee
Gunvant Devichand Oswal
Pooja Gunvant Oswal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunvant Devichand Oswal, Pooja Gunvant Oswal filed Critical Gunvant Devichand Oswal
Publication of MY161415A publication Critical patent/MY161415A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI2010005054A 2008-04-29 2009-04-27 A homeopathic formulation MY161415A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN940MU2008 2008-04-29

Publications (1)

Publication Number Publication Date
MY161415A true MY161415A (en) 2017-04-14

Family

ID=54253313

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2010005054A MY161415A (en) 2008-04-29 2009-04-27 A homeopathic formulation

Country Status (15)

Country Link
US (1) US20110038949A1 (pt)
EP (1) EP2296681A4 (pt)
JP (2) JP2011518876A (pt)
KR (1) KR101321031B1 (pt)
CN (1) CN102014939A (pt)
AU (1) AU2009241221B2 (pt)
BR (1) BRPI0912026A2 (pt)
CA (1) CA2722121A1 (pt)
CH (1) CH701268B1 (pt)
EA (1) EA201001592A1 (pt)
IL (1) IL208902A (pt)
MX (1) MX339704B (pt)
MY (1) MY161415A (pt)
SG (1) SG190594A1 (pt)
WO (1) WO2009133573A2 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0917684A2 (pt) * 2008-08-29 2015-12-01 Nancy Josephine Polich método terapêutico homeopático
WO2011085307A1 (en) * 2010-01-11 2011-07-14 Phoenix Biotechnology, Inc. Method of treating neurological conditions with cardiac glycosides
EP2568958A1 (en) * 2010-05-14 2013-03-20 Deseret Biologicals, Inc. Formulations of diluted genetic material and methods for making same
FR2962909A1 (fr) * 2010-07-21 2012-01-27 Oleg Iliich Epshtein Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees avec une maladie ou affection respiratoire
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
US9603898B2 (en) 2011-03-23 2017-03-28 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
CN114306171A (zh) * 2011-03-28 2022-04-12 玫琳凯有限公司 局部皮肤用组合物及其用途
US9545429B1 (en) * 2011-09-03 2017-01-17 Biolyte Laboratories, Llc Homeopathic formulations
EP2591823A1 (en) * 2011-11-11 2013-05-15 Biologische Heilmittel Heel GmbH Composition for treating or preventing neurodegenerative disorders
RU2484839C1 (ru) * 2012-02-06 2013-06-20 Михаил Михайлович Шашурин Способ получения экстракта рододендрона золотистого с пониженным содержанием стероидных (сердечных) гликозидов
WO2013138306A1 (en) 2012-03-15 2013-09-19 Princeton Biotechnology Corporation Compositions and methods for treatment of pain
US8551535B1 (en) 2012-08-06 2013-10-08 Sarah McCann Homeopathic remedies and methods for enhancing weight loss
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
WO2015030567A1 (es) * 2013-08-30 2015-03-05 Zamarripa Blas Juan Alberto Mejoras a formulación auxiliar para contrarrestar efectos adversos de tratamientos contra el cáncer y de tratamientos contra algunas enfermedades víricas
KR101540107B1 (ko) * 2015-02-05 2015-07-30 주식회사 다림바이오텍 반복적 희석 및 진탕을 이용한 경구용 제제의 제조방법
US20170290873A1 (en) * 2016-04-08 2017-10-12 Stellalife Method Of Using Homeopathic Kit Containing Gel, Rinse And Spray For Management Of Post-Oral Surgical Recovery And Maintenance Of Oral Health
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
US10828251B1 (en) 2017-01-14 2020-11-10 Biolyte Laboratories, Llc Homeopathic formulations
US10617634B1 (en) 2017-03-10 2020-04-14 Biolyte Laboratories, Llc Topical homeopathic formulations for menstrual cramps
WO2019104442A1 (en) * 2017-11-30 2019-06-06 Canopy Growth Corporation Liquid dosage forms, methods of making and use
WO2020072850A1 (en) * 2018-10-04 2020-04-09 Stellalife, Inc. Compositions and methods for promoting and maintaining oral health
EP4069215A4 (en) 2019-12-06 2024-01-17 Jlabs Beauty LLC TOPICAL COMPOSITIONS CONTAINING ROSE OIL AND CANNABIDIOL AND METHODS OF PREPARING AND USING THE SAME
KR102273322B1 (ko) * 2020-04-29 2021-07-06 우보한의연구소(주) 복합 한약재 추출물을 유효성분으로 포함하는 알츠하이머병 예방, 치료, 또는 개선용 조성물
RU2746080C1 (ru) * 2020-07-20 2021-04-06 Сергей Анатольевич Небера Гомеопатическое средство для купирования тика век
EP4368172A1 (de) * 2022-11-11 2024-05-15 Gernot A. Overbeck Verfahren zur herstellung eines analogen homöopathischen wirkstoffs, vorrichtung zur durchführung des verfahrens und computerprogrammprodukt

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2073515C1 (ru) * 1993-01-20 1997-02-20 Игорь Электринович Острейковский Способ лечения травматического поражения головного мозга
RU2074714C1 (ru) * 1993-03-11 1997-03-10 Игорь Электринович Острейковский Способ лечения пациентов с поражением центральной нервной системы
US20060088575A1 (en) * 1994-03-31 2006-04-27 Brewitt Barbara A Homeopathic preparations of purified growth factors and purified growth hormones and associated carriers
DE19738903A1 (de) * 1997-09-05 1999-03-11 Reimar Dr Med Banis Stoffe
RU2143275C1 (ru) * 1999-05-06 1999-12-27 Общество с ограниченной ответственностью "Доктор Н" Гомеопатическое лекарственное средство для лечения бессонницы и повышенной нервной возбудимости "валериана-плюс мультигран"
RU2150288C1 (ru) * 1999-10-25 2000-06-10 Небера Сергей Анатольевич Гомеопатическое средство для лечения спазма аккомодации
RU2224526C1 (ru) * 2002-11-04 2004-02-27 Государственное учреждение Научно-исследовательский институт психического здоровья Томского научного центра СО РАМН Средство для профилактики и лечения боевой психической травмы
CA2518965C (en) * 2003-03-14 2018-10-30 Nutrition Research Inc. Homeopathic formulations useful for treating pain and/or inflammmation
US7037532B2 (en) * 2004-03-03 2006-05-02 Innovation Ventures, Llc Hangover relief composition
US20050249763A1 (en) * 2004-04-19 2005-11-10 L'oreal Kit for formulating a cosmetic product
US20060165812A1 (en) * 2005-01-21 2006-07-27 Amershire Investment Corporation Method and topical formulation for treating headaches
US20070275096A1 (en) * 2006-05-19 2007-11-29 Trp, Inc., A Nevada Corporation Composition and methodology for the treatment of hearing impairment symptoms
WO2009047004A1 (en) * 2007-10-10 2009-04-16 Daniel Farrington A homeopathic complex

Also Published As

Publication number Publication date
JP2014062106A (ja) 2014-04-10
CN102014939A (zh) 2011-04-13
US20110038949A1 (en) 2011-02-17
JP5819909B2 (ja) 2015-11-24
EP2296681A4 (en) 2012-04-18
EA201001592A1 (ru) 2011-08-30
KR20100137013A (ko) 2010-12-29
AU2009241221A1 (en) 2009-11-05
EP2296681A2 (en) 2011-03-23
CH701268B1 (de) 2012-06-15
WO2009133573A3 (en) 2010-05-06
WO2009133573A2 (en) 2009-11-05
MX2010011715A (es) 2010-12-06
CA2722121A1 (en) 2009-11-05
MX339704B (es) 2016-06-06
KR101321031B1 (ko) 2013-10-23
AU2009241221B2 (en) 2015-02-05
BRPI0912026A2 (pt) 2015-10-06
IL208902A0 (en) 2011-01-31
JP2011518876A (ja) 2011-06-30
SG190594A1 (en) 2013-06-28
IL208902A (en) 2015-09-24

Similar Documents

Publication Publication Date Title
MY161415A (en) A homeopathic formulation
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
MX2009009491A (es) Compuestos y composiciones como moduladores de la actividad del gpr119.
WO2009129246A3 (en) Compositions and methods for preparing and using same
MX2007009356A (es) Compuestos y composiciones como moduladores de ppar.
MX2012004078A (es) Compuestos y composiciones como moduladores de la actividad de gpr119.
AU2007257423A8 (en) Purine analogs
WO2009012176A3 (en) Methods and compositions for treating brain diseases
MX2010004219A (es) Agentes de enlace de cd19 y usos de los mismos.
MX2009007944A (es) Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium.
MX2009006339A (es) Compuestos y composiciones como inhibidores de actividad de receptor 1 de cannabinoide.
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
WO2011027222A3 (en) Immunogenic compositions including tlr activity modulators
MX2012002654A (es) Compuestos y composiciones como moduladores de la actividad de tlr.
TW200732296A (en) Novel compounds
SG179120A1 (en) Novel compounds
WO2010151799A3 (en) Compounds for modulating rna binding proteins and uses therefor
MX2011002889A (es) Metodo de uso de una cepa de bacillus subtilis para mejorar la salud de animales.
MX2009010207A (es) Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c.
TW200602330A (en) Compounds and compositions as PPAR modulators
WO2010151797A3 (en) Compounds for modulating rna binding proteins and uses therefor
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
MX2012004548A (es) Nuevas composiciones para prevenir y/o tratar transtornos degenerativos del sistema nervioso central.
MX2010000098A (es) Derivados de guanina policiclicos y sus metodos de uso.